Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 7;79(6):437-445.
doi: 10.1093/ajhp/zxab422.

Pharmacotherapy for nontuberculous mycobacterial pulmonary disease

Manasa Velagapudi  1 , Michael J Sanley  2 , Sumaya Ased  3 , Chris Destache  4 , Mark A Malesker  4
Affiliations

Pharmacotherapy for nontuberculous mycobacterial pulmonary disease

Manasa Velagapudi et al. Am J Health Syst Pharm. .

Abstract

Purpose: To provide an updated review of the diagnosis and pharmacotherapy of nontuberculous mycobacteria pulmonary disease (NTM-PD) and summarize guideline recommendations for an interdisciplinary treatment approach.

Summary: A systemic approach was taken in which all articles in English in MEDLINE and PubMed were reviewed. The US National Library of Medicine's DailyMed database was used to assess drug package inserts. Analysis of NTM treatment guidelines is summarized in the article with a focus on medications, dosing, interactions, and medication monitoring.

Conclusion: It is critical to manage patients with NTM with a multidisciplinary team approach. Treatment is prolonged and expensive, and the potential for drug toxicity, adverse effects, and drug interactions requires monitoring. Clinical pharmacists play a role in the management of NTM.

Keywords: Mycobacterium abscessus; Mycobacterium avium; Mycobacterium xenopi; NTM; inhaled amikacin; nontuberculous mycobacterial pulmonary disease.

PubMed Disclaimer

MeSH terms